No Detail Found!

Profiling of inflammatory biomarkers in mild to critically ill severe acute respiratory syndrome corona virus-19 (SARS Covid-19) patients from Karachi, Pakistan

Author(s)
Junaid Mahmood Alam Department of Clinical Biochemistry Lab Services and Chemical Pathology, Liaquat National Hospital and Medical College,Karachi,
Sarah Sughra Asghar Department of Anatomy, Sir Syed College of Medical Sciences for Girls,Karachi,Pakistan
Humaira Ali Department of Clinical Biochemistry Lab Services and Chemical Pathology, Liaquat National Hospital and Medical College,Karachi,
Syed Riaz Mahmood Department of Pathology, Lyari General Hospital,Karachi,Pakistan
Maqsood Ali Ansari Department of Genetics, University of Karachi,Karachi,Pakistan
Abstract
SARS-Covid-19 infection got spread in many countries and WHO declared it as a serious global Pandemic. Pro-inflammatory cytokines storm generated by Covid-19 infection hyper-activates inflammatory response in host body, resulting in elevated release of inflammatory biomarkers. Present article describes the characteristic profile of these inflammatory and related biomarkers in a total of 48 critically ill Covid-19 patients, (Male = 38, F = 10), with mildly ill to severe, critically ill status and thus grouped accordingly. Inflammatory Biomarkers, Ferritin, ProCalcitonin, CReactive Protein, coagulation marker-D-Dimer, chemical analytes, Protein, Albumin, BUN, Bilirubin, Creatinine, and enzymes, Lactate Dehydrogenase, ?-Glutamyl transpeptidases, Alkaline phosphatase were routine analyzed by standard methods described earlier. D-dimer, Ferritin, CRP and Procalcitonin exhibited variable alterations (P<0.05 to P<0.001), more markedly in critically ill patients than in the mild and severe. Biochemical analytes and enzymatic parameters showed elevated levels (P<0.05 to P<0.01) mostly in critically ill category of patients when compared with mild or severe, except total protein and albumin, which remained non-significant. It is concluded that cytokine, chemokines and pro-inflammatory markers, which released in abnormally high concentrations in Covid-19 patients of variable syndrome intensity, are significant indicators of disease severity, progression and success of treatments. As the pharmacological options may vary with the different stages of the disease therefore identifying the correct stage of the disease may be very useful in selecting the best option.
Publication Details
Page(s) 429-433
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: S1, Year: 2021

Request the full text from PASTIC

Keywords
syndrome intensity, COVID-19, Covid-19, Biomarkers
References
Alam JM,Ali H JM .2020 .Significance of Ferritin as Biomarker in SARS Corona virus (Covid-19) infection and complications: A review. Chem, 5(6) : 59-64.
Alam JM,Matinuddin S,Amin A,Mahmood SK .2020 .Quality check, comparative precision and standardization of liver function test (LFTs) parameters on two identical standalone Cobas c501 analyzers, organized 24/7 and operated by different sets of lab technologists. Chem. Res. J., 5(2) : 88-95.
Alam JM,Sultana I JM .2015 .Revalidation of existing IFCC standardized hepatic and thyroid function tests by precision optimization and external quality assurance programs. Amer. Euro-Asian J. Sci. Res, 10(6) : 234-238.
Al-Samkari H,Leaf RSK,Dzik WH,Carlson JCT,Fogerty AE,Waheed A,Goodarzi K,Bendapudi PK,Bornikova L,Gupta S,Leaf DE,Kuter DJ,Rosovsky RP .2020 .COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV2 infection. Blood, 136(4) : 489-500.
Caruso FP,Scala G,Cerulo L,Ceccarelli M .2020 .A review of Covid-19 biomarkers and drug targets: resources and tools. , : .
Chen N,Zhou M,Dong X,Qu J,Gong F,Han Y,Qiu Y,Wang J,Liu Y,Wei Y,Xia J,Yu T,Zhang X,Zhang L X .2020 .Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 395(10223) : 507-513.
Fox SE,Akmatbekov A,Harbert JL,Li G,Brown JQ,Vander Heide RS .2020 .Pulmonary and cardiac pathology in African American patients with COVID19: an autopsy series from New Orleans. Lancet Respir. Med, 8(7) : 681-686.
Gao M,Monian P,Pan Q,Zhang W,Xiang J,Jiang X .2016 .Ferroptosis is an autophagic cell death process. Cell Res, 26(9) : 1021-1032.
Gong J,Dong H,Xia Q,Huang Z,Wang Z,Zhao Y,Liu W,Tu S,Zhang M,Wang Q,Lu F Q .2020 .Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19 Pneumonia. BMJ Med, : .
Guaraldi G,Meschiari M,Cozzi-Lepri A,Milic J,Tonelli R,Menozzi M,Franceschini E,Cuomo G,Orlando G,Borghi V,Santoro A,Di Gaetano M,Puzzolante C,Carli F,Bedini A,Corradi L,Fantini R,Castaniere I,Tabbì L,Girardis M,Tedeschi S,Giannella M,Bartoletti M,Pascale R,Dolci G,Brugioni L,Pietrangelo A,Cossarizza A,Pea F,Clini E,Salvarani C,Massari M,Viale PL,Mussini C .2020 .Tocilizumab in patients with severe COVID-19: A retrospective cohort study. Lancet Rheumatol, 2(8) : e474-e484.
Guan WJ,Ni ZY,Hu Y,Liang W,Ou CQ,He JX,Liu L JX .2020 .China medical treatment expert group for covid-19. clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med, 382(18) : 1708-1720.
Hadjadj J,Yatim N,Barnabei L,Corneau A,Boussier J,Smith N,Pere H,Charbit B,Bondet V,ChenvierGobeaux C,Breillat P,Carlier N,Gauzit R,Morbieu C,Pene F,Marin N,Roche N,Szwebel A,Merkling SH,Treluyer JM,Veyer D,Mouthon L,Blanc C,Tharaux PL,Rozenberg F,Fischer A,Duffy D,Rieux-Laucat F,Kerneis S,Terrier B .2020 .Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. , 369(6504) : 718-724.
Huang C,Wang Y,Li X,Ren L,Zhao J,Hu Y,Zhang L,Fan G,Xu J,Gu X,Cheng Z,Yu T,Xia J,Wei Y,Wu W,Xie X,Yin W,Li H,Liu M,Xiao Y,Gao H,Guo L,Xie J,Wang G,Jiang R,Gao Z,Jin Q,Wang J,Cao B .2020 .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. , 395(10223) : 497-506.
Liu F,Li L,Xu M,Wu J,Luo D,Zhu Y,Li B,Song X,Zhou X .2020 .Prognostic value of Interleukin 6, C-reactive protein and procalcitonin in patients with Covid-19. , 104347 : .
Matinuddin S,Alam JM,Mahmood SK,Amin M .2018 .Iron profile status and its usefulness in the assessment of iron deficiencies in selected population. Chem. Res. J., 3(1) : 98-102.
Mehta P,McAuley DF,Brown M,Sanchez E,Tattersall RS,Manson JJ .2020 .Consider cytokine storm syndromes and immuno-suppression. Lancet, 395(10229) : 1033-1034.
Mo P,Xing Y,Xiao Y,Deng L,Zhao Q,Xiong Y,Cheng Y,Gao S,Liang K,Luo M,Chen T,Song S,Ma Z,Chen X,Zheng R,Cao Q,Wang F,Zhang Y F .2020 .Clinical characteristics of refractory Covid-19 pneumonia in Wujan China. Clin. Infect, : .
Ribas CD,Mehra MR .2020 .COVID-19 illness in native and immunosuppressed states: A clinicaltherapeutic staging proposal. J. Heart Lung Transplant, 39(5) : 405-407.
Smith K,Pace A,Ortiz S,Kazani S,Rottinghaus S S .2020 .A Phase 3 open-label, randomized, controlled study to evaluate the efficacy and safety of intravenously administered ravulizumab compared with best supportive care in patients with COVID-19 severe pneumonia, acute lung injury, or acute respiratory distress syndrome: A structured summary of a study protocol for a randomised controlled trial. Trails, 13(1) : 639.
Siripanthong B,Nazarian S,Muser D,Deo R,Samtangeli P,Khanji MY,Copper LT,Chahal CAA .2020 .Recognizing COVID-19 related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm, 17(9) : 1463-1471.
.1995 .. , : 268-383.
Toubiana J,Poirault C,Corsia A,Bajolle F,Fourgeaud J,Angoulvant F,Debray A,Basmaci R,Salvador E,Biscardi S,Frange P,Chalumeau M,Casanova JL,Cohen JF,Allali S JF .2020 .Kawasaki-like multisystem inflammatory syndrome in children during the covid-. BMJ, : .
Velavan TP,Meyer CG .2020 .Mild versus severe COVID-19: Laboratory markers. Int. J. Inf. Dis., 95 : 304-307.
Wang D,Hu B,Hu C,Zhu F,Liu X,Zhang J,Wang B,Xiang H. Cheng Z,Xiong Y,Zhao Y,Li Y,Wang X,Peng Z .2020 .Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan. China: JAMA, 323(11) : 1061-1069.
Wang F,Hou H,Luo Y,Tang G,Wu S,Huang M,Liu W,Zhu Y,Lin Q,Mao L,Fang M,Zhang H,Sun Z H .2020 .The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight, 5(10) : e137799.
Dec .2020 .Accessed 5. , 19(March) : .
Zeng F,Huang Y,Guo Y,Yin M,Chen X,Xio L,Deng G .2020 .Association of inflammatory markers with severity of COVID-19: A meta-analysis. Int. J. Infect. Dis., 96 : 467-474.
0

Citations

0

Downloads

10

Views